Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Unresectable giant pancreatic neuroendocrine tumor effectively treated by high-intensity focused ultrasound: a case report and review of the literature.

Chen Q, Zhu X, Chen Q, Wang K, Meng Z.

Pancreatology. 2013 Nov-Dec;13(6):634-8. doi: 10.1016/j.pan.2013.10.001. Epub 2013 Oct 10.

PMID:
24280584
2.

High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity.

Marinova M, Rauch M, Mücke M, Rolke R, Gonzalez-Carmona MA, Henseler J, Cuhls H, Radbruch L, Strassburg CP, Zhang L, Schild HH, Strunk HM.

Eur Radiol. 2016 Nov;26(11):4047-4056. Epub 2016 Feb 17.

PMID:
26886904
3.

Clinical Use of High-Intensity Focused Ultrasound (HIFU) for Tumor and Pain Reduction in Advanced Pancreatic Cancer.

Strunk HM, Henseler J, Rauch M, Mücke M, Kukuk G, Cuhls H, Radbruch L, Zhang L, Schild HH, Marinova M.

Rofo. 2016 Jul;188(7):662-70. doi: 10.1055/s-0042-105517. Epub 2016 Jun 7.

4.

High-intensity focused ultrasound treatment for patients with unresectable pancreatic cancer.

Li PZ, Zhu SH, He W, Zhu LY, Liu SP, Liu Y, Wang GH, Ye F.

Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):655-60.

PMID:
23232639
5.

Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer.

Wang K, Chen Z, Meng Z, Lin J, Zhou Z, Wang P, Chen L, Liu L.

Int J Hyperthermia. 2011;27(2):101-7. doi: 10.3109/02656736.2010.525588. Epub 2011 Jan 10.

PMID:
21219135
6.

[Radiofrequency ablation of pancreatic neuroendocrine tumor].

Hlavsa J, Procházka V, Kala Z, Man M, Andrasina T, Cíhalová M, Válek V, Crha M, Svobodová I, Urbanová L.

Klin Onkol. 2011;24(3):209-15. Czech.

PMID:
21717790
7.

High-intensity focused ultrasound treatment of late-stage pancreatic body carcinoma: optimal tumor depth for safe ablation.

Ge HY, Miao LY, Xiong LL, Yan F, Zheng CS, Wang JR, Jia JW, Cui LG, Chen W.

Ultrasound Med Biol. 2014 May;40(5):947-55. doi: 10.1016/j.ultrasmedbio.2013.11.020. Epub 2014 Jan 22.

PMID:
24462161
8.

Correlation between ultrasound reflection intensity and tumor ablation ratio of late-stage pancreatic carcinoma in HIFU therapy: dynamic observation on ultrasound reflection intensity.

Ge HY, Miao LY, Wang JR, Xiong LL, Yan F, Zheng CS, Jia JW, Cui LG, Chen W.

ScientificWorldJournal. 2013 Dec 26;2013:852874. doi: 10.1155/2013/852874. eCollection 2013.

9.

High intensity focused ultrasound ablation of pancreatic neuroendocrine tumours: report of two cases.

Orgera G, Krokidis M, Monfardini L, Bonomo G, Della Vigna P, Fazio N, Orsi F.

Cardiovasc Intervent Radiol. 2011 Apr;34(2):419-23. doi: 10.1007/s00270-010-9884-0. Epub 2010 Jun 3.

PMID:
20521049
10.

Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.

Fujimori N, Osoegawa T, Lee L, Tachibana Y, Aso A, Kubo H, Kawabe K, Igarashi H, Nakamura K, Oda Y, Ito T.

Scand J Gastroenterol. 2016;51(2):245-52. doi: 10.3109/00365521.2015.1083050. Epub 2015 Sep 11.

PMID:
26513346
11.

Ultrasound Guided High Intensity Focused Ultrasound for malignant tumors: The Spanish experience of survival advantage in stage III and IV pancreatic cancer.

Vidal-Jove J, Perich E, del Castillo MA.

Ultrason Sonochem. 2015 Nov;27:703-6. doi: 10.1016/j.ultsonch.2015.05.026. Epub 2015 May 27.

PMID:
26044461
12.

Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.

Sugimoto M, Takagi T, Hikichi T, Suzuki R, Watanabe K, Nakamura J, Kikuchi H, Konno N, Waragai Y, Asama H, Takasumi M, Watanabe H, Obara K, Ohira H.

World J Gastroenterol. 2015 Jul 14;21(26):8118-24. doi: 10.3748/wjg.v21.i26.8118.

13.

Harmonic motion imaging for abdominal tumor detection and high-intensity focused ultrasound ablation monitoring: an in vivo feasibility study in a transgenic mouse model of pancreatic cancer.

Chen H, Hou GY, Han Y, Payen T, Palermo CF, Olive KP, Konofagou EE.

IEEE Trans Ultrason Ferroelectr Freq Control. 2015 Sep;62(9):1662-73. doi: 10.1109/TUFFC.2015.007113.

14.

Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases.

Wang G, Zhou D.

Ultrason Sonochem. 2015 Nov;27:694-702. doi: 10.1016/j.ultsonch.2015.05.029. Epub 2015 Jun 9.

PMID:
26113389
15.

High intensity focused ultrasound: a noninvasive therapy for locally advanced pancreatic cancer.

Wu F.

World J Gastroenterol. 2014 Nov 28;20(44):16480-8. doi: 10.3748/wjg.v20.i44.16480. Review.

16.

Advances of high intensity focused ultrasound (HIFU) for pancreatic cancer.

Xiaoping L, Leizhen Z.

Int J Hyperthermia. 2013 Nov;29(7):678-82. doi: 10.3109/02656736.2013.837199. Review.

PMID:
24102396
17.

Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences.

Lee JY, Choi BI, Ryu JK, Kim YT, Hwang JH, Kim SH, Han JK.

Korean J Radiol. 2011 Mar-Apr;12(2):176-86. doi: 10.3348/kjr.2011.12.2.176. Epub 2011 Mar 3.

18.

[Efficacy evaluation of high intensity focused ultrasound combined with intra-arterial infusion of gemcitabine in the treatment of pancreatic cancer].

Zhong GC, Zhang XY, Chen J, Sun Y, Zhang WH, Gui YZ, Long HX, Zhu B.

Zhonghua Zhong Liu Za Zhi. 2012 Jan;34(1):68-72. Chinese.

PMID:
22490861
19.

Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer.

Sofuni A, Moriyasu F, Sano T, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, Tsuji S, Ikeuchi N, Tanaka R, Umeda J, Tonozuka R, Honjo M, Mukai S, Fujita M, Itoi T.

World J Gastroenterol. 2014 Jul 28;20(28):9570-7. doi: 10.3748/wjg.v20.i28.9570.

20.

Magnetic resonance-guided high-intensity focused ultrasound treatment of locally advanced pancreatic adenocarcinoma: preliminary experience for pain palliation and local tumor control.

Anzidei M, Marincola BC, Bezzi M, Brachetti G, Nudo F, Cortesi E, Berloco P, Catalano C, Napoli A.

Invest Radiol. 2014 Dec;49(12):759-65. doi: 10.1097/RLI.0000000000000080.

PMID:
24932986

Supplemental Content

Support Center